The company recorded revenue from operations growth of 18 per ... especially among long-term investors hunting for value in pharma stocks. The India-branded formulations segment remained the clear ...

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India’s largest listed pharma company, Sun Pharmaceutical Industries (Sun Pharma), was under pressure on ...

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 ... and genetic data as part of the deal. The pharma giant said it plans to use the 23andMe ...

Finally, Maxim Group boosted their price target on Medicus Pharma from $10.00 to $20.00 and gave the company a “buy” rating in a research note on Thursday, May 8th. One equities research ...

"Recommended a Final dividend of Re 0.10 per share, subject to approval of members at the ensuing Annual General Meeting," said the pharma company in its exchange filing. “Approval of material ...

The U.K. pharma company said Monday that the combinations were approved for the treatment of adults with relapsed or refractory multiple myeloma, and that this was the second major approval for ...

But what if you designed a big pharma company from scratch based on the current world? What if we threw it all out and started again with pharma 2.0? It’s an interesting thought experiment I ...

Mumbai-based Koye is the first pharma company to partner with Sonde Health on the technology, which is also being used in a standalone app to monitor people's mental health and wellbeing.

"Recommended a Final dividend of Re 0.10 per share subject to approval of members at the ensuing Annual General Meeting," the pharma company said. Besides, the board of Sigachi Industries also ...

While the company is showing early signs of recovery and margin improvement, a high valuation means risks remain. Key pharma stocks, including Granules India and Gland Pharma, have shown ...

17,672 equity shares of Trimax Bio Sciences Pvt Ltd. The acquisition is expected to bolster the company’s R&D capabilities and product diversification in the nutraceutical and pharma ingredient ...

The company entered into an agreement with Invent Pharma, Spain for the development and supply of injectible products to a joint venture company for marketing in Spain and Portugal. Also ...